Terms: = Head and neck cancer AND MLF1, P58340, 4291, ENSG00000178053 AND Treatment
3 results:
1. Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial.
Jiang Z; Xie Y; Zhang W; Du C; Zhong Y; Zhu Y; Jiang L; Dou L; Shao K; Sun Y; Xue Q; Tian Y; Gao S; Zhao D; Zhou A
Gastric Cancer; 2024 May; 27(3):571-579. PubMed ID: 38457083
[TBL] [Abstract] [Full Text] [Related]
2. High-Risk Cutaneous Squamous Cell cancer of the head and neck: Risk Factors for Recurrence and Impact of Adjuvant treatment.
Trosman SJ; Zhu A; Nicolli EA; Leibowitz JM; Sargi ZB
Laryngoscope; 2021 Jan; 131(1):E136-E143. PubMed ID: 32065413
[TBL] [Abstract] [Full Text] [Related]
3. PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.
Tauzin M; Rabalais A; Hagan JL; Wood CG; Ferris RL; Walvekar RR
World J Surg Oncol; 2010 Aug; 8():70. PubMed ID: 20712875
[TBL] [Abstract] [Full Text] [Related]
